HEMATOLOGY

Latest News

FDA Wraps Up End Of Phase 2 Meeting for AML Combination Therapy
FDA Wraps Up End Of Phase 2 Meeting for AML Combination Therapy

July 10th 2024

The completion of the End of Phase 2 meeting for the phase 1B/2 trial of annamycin and cytarabine in acute myeloid leukemia has been announced.

COMMANDS Trial Shows Positive Result in MDS Despite Pandemic
COMMANDS Trial Shows Positive Result in MDS Despite Pandemic

July 9th 2024

DSP-5336 Displays Promise in Early Trials for NPM1/KMT2A+ Acute Leukemia
DSP-5336 Displays Promise in Early Trials for NPM1/KMT2A+ Acute Leukemia

July 9th 2024

A Deep Dive Into the FDA Approval of Imetelstat in Lower-Risk MDS
A Deep Dive Into the FDA Approval of Imetelstat in Lower-Risk MDS

July 1st 2024

Cost Savings Associated with Zanubrutinib Over Acalabrutinib in B-Cell Malignancies
Cost Savings Associated with Zanubrutinib Over Acalabrutinib in B-Cell Malignancies

June 28th 2024

Video Series
Video Interviews

More News